Top 10 Penny Stocks To Watch In December 2024

As the U.S. stock market navigates a holiday-shortened week with notable gains in major indices, investors are paying close attention to broader economic signals and corporate developments. For those interested in exploring opportunities beyond the mainstream, penny stocks—despite their somewhat antiquated name—remain an intriguing area of investment. These stocks often represent smaller or newer companies that, when underpinned by strong financials, can offer potential for substantial returns.

Top 10 Penny Stocks In The United States
Name Share Price Market Cap Financial Health Rating
Inter & Co (NasdaqGS:INTR) $4.21 $1.85B ★★★★☆☆
QuantaSing Group (NasdaqGM:QSG) $3.08 $103.25M ★★★★★★
BAB (OTCPK:BABB) $0.8849 $6.43M ★★★★★★
ZTEST Electronics (OTCPK:ZTST.F) $0.2399 $8.83M ★★★★★★
Imperial Petroleum (NasdaqCM:IMPP) $2.84 $86.14M ★★★★★★
Permianville Royalty Trust (NYSE:PVL) $1.33 $43.89M ★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M ★★★★★★
BTCS (NasdaqCM:BTCS) $2.855 $49.54M ★★★★★★
Smith Micro Software (NasdaqCM:SMSI) $1.27 $22.53M ★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT) $0.8502 $76.47M ★★★★★☆

Click here to see the full list of 739 stocks from our US Penny Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Grab Holdings (NasdaqGS:GRAB)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Grab Holdings Limited operates as a superapp provider across Southeast Asia, offering various services in countries such as Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam; it has a market cap of approximately $19.89 billion.
Operations: Grab Holdings Limited has not reported specific revenue segments.
Market Cap: $19.89B
Grab Holdings Limited, despite being unprofitable, maintains a robust financial position with short-term assets of $6.5 billion surpassing both its long-term liabilities ($321 million) and short-term liabilities ($2.4 billion). The company has sufficient cash runway for over three years due to positive free cash flow growth. Recent activities include a share buyback program, repurchasing 1.45% of shares for $189.4 million, and an upward revision in revenue guidance for 2024 to $2.76-$2.78 billion, reflecting solid operational momentum despite shareholder dilution and management's relatively new tenure averaging 2 years.
Unlock comprehensive insights into our analysis of Grab Holdings stock in this financial health report.
Examine Grab Holdings' earnings growth report to understand how analysts expect it to perform.
NasdaqGS:GRAB Revenue & Expenses Breakdown as at Dec 2024
Energy Vault Holdings (NYSE:NRGV)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Energy Vault Holdings, Inc. develops and sells energy storage solutions with a market cap of $305.76 million.
Operations: The company generates revenue from its Electric Equipment segment, amounting to $130.96 million.
Market Cap: $305.76M
Energy Vault Holdings, Inc. faces challenges with declining revenue, reporting US$1.2 million for Q3 2024 compared to US$172.21 million a year prior, and ongoing unprofitability with increased losses over five years. Despite these hurdles, the company has formed a strategic partnership with RackScale Data Centers to deploy its high-density B-Nest™ energy storage systems, potentially accelerating data center power solutions amidst grid constraints. While Energy Vault's cash runway is limited to six months based on free cash flow estimates, recent capital raising efforts may provide some financial relief as it navigates volatility and shareholder dilution concerns.
Get an in-depth perspective on Energy Vault Holdings' performance by reading our balance sheet health report here.
Understand Energy Vault Holdings' earnings outlook by examining our growth report.
NYSE:NRGV Financial Position Analysis as at Dec 2024
Planet Labs PBC (NYSE:PL)
Simply Wall St Financial Health Rating: ★★★★★★★
Overview: Planet Labs PBC designs, constructs, and launches satellite constellations to provide high cadence geospatial data via an online platform globally, with a market cap of approximately $1.23 billion.
Operations: The company's revenue is primarily generated from its data processing segment, totaling $241.65 million.
Market Cap: $1.23B
Planet Labs PBC, a satellite data provider, reported third-quarter sales of US$61.27 million, up from US$55.38 million the previous year, while reducing its net loss to US$20.08 million from US$38 million. Despite being unprofitable and experiencing shareholder dilution with a 3.2% increase in shares outstanding over the past year, Planet Labs maintains a strong cash position with short-term assets of US$301.6 million exceeding liabilities and no debt on its balance sheet. Recent product advancements include high-resolution Pelican-2 satellites equipped with AI technology for rapid data processing and expanded contracts like one with Colombia's National Police.
As the U.S. stock market navigates a holiday-shortened week with notable gains in major indices, investors are paying close attention to broader economic signals and corporate developments. For those interested in exploring opportunities beyond the mainstream, penny stocks—despite their somewhat antiquated name—remain an intriguing area of investment. These stocks often represent smaller or newer companies that, when underpinned by strong financials, can offer potential for substantial returns.
Top 10 Penny Stocks In The United States
Name Share Price Market Cap Financial Health Rating
QuantaSing Group (NasdaqGM:QSG) $3.08 $99.16M ★★★★★★
Inter & Co (NasdaqGS:INTR) $4.21 $1.91B ★★★★☆☆
BAB (OTCPK:BABB) $0.8849 $6.46M ★★★★★★
Pangaea Logistics Solutions (NasdaqCM:PANL) $4.95 $227.01M ★★★★★☆
ZTEST Electronics (OTCPK:ZTST.F) $0.24 $7.76M ★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M ★★★★★★
Permianville Royalty Trust (NYSE:PVL) $1.36 $45.54M ★★★★★★
PHX Minerals (NYSE:PHX) $3.74 $142.05M ★★★★★☆
Smith Micro Software (NasdaqCM:SMSI) $1.26 $17.19M ★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT) $0.80 $70.15M ★★★★★☆

Click here to see the full list of 742 stocks from our US Penny Stocks screener.
Let's dive into some prime choices out of the screener.
AbCellera Biologics (NasdaqGS:ABCL)
Simply Wall St Financial Health Rating: ★★★★★★★
Overview: AbCellera Biologics Inc. operates as a company focused on antibody drug discovery and development, with a market cap of approximately $841.79 million.
Operations: The company's revenue segment includes $32.96 million from the discovery and development of antibodies.
Market Cap: $841.79M
AbCellera Biologics, with a market cap of US$841.79 million, remains an intriguing penny stock due to its focus on antibody drug discovery. Despite being unprofitable and experiencing increased losses over the past five years, the company benefits from a robust balance sheet with short-term assets of US$742.9 million significantly surpassing both short-term and long-term liabilities. The absence of debt reduces financial risk, and no recent shareholder dilution is evident. However, revenue growth is modest at 16.47% annually while earnings are expected to decline by 10.7% per year over the next three years, indicating potential challenges ahead.
Get an in-depth perspective on AbCellera Bi